Epidermolysis bullosa acquisita

Dermatology Online Journal

Volumn 13, Issue 1, 2007, Pages

  Stein, Jennifer A ^a   Mikkilineni, Radha ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; DAPSONE; IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANAMNESIS; ARTICLE; BLISTER; CASE REPORT; EOSINOPHIL; EPIDERMOLYSIS BULLOSA ACQUISITA; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; SKIN BIOPSY; BIOPSY; DIFFERENTIAL DIAGNOSIS; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; FOOT; HAND; IMMUNOLOGY; METABOLISM; PATHOLOGY; SKIN;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; DAPSONE; DIAGNOSIS, DIFFERENTIAL; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOLLOW-UP STUDIES; FOOT; HAND; HUMANS; IMMUNOGLOBULIN G; SKIN;

EID: 33846821652     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Woodley D, et al. Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984;310:1007
2. Bernard P, et al. Incidence and distribution of subepidermal autoimmune bullous diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995;131:48
3. Gammon WR, et al. Epidermolysis bullosa acquisita - a pemphigoid-like disease. J Am Acad Dermatol. 1984, 11: 820
4. Borradori L, Bernard P, Pemphigoid Group. In: Bolognia J, et al., eds. Dermatology. London: Mosby, 2003: 463
5. Vodegel RM, et al. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol. 2002;47:919
6. Borradori L, et al. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 1995;131:590
7. Sitaru C, et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 2005;115:870
8. Woodley D, et al. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005;124:958
9. Gammon WR, et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-basement membrane zone antibodies by indirect immunofluoresence on 1.0 M sodium chloride separated skin. J Invest Dermatol 1984;82:139
10. Fine JD Management of acquired bullous skin diseases. N Engl J Med 1995;333:1475
11. Schmidt E, et al. Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab. Arch Dermatol 2006;142:147